Published 2006 | Version v1
Miscellaneous Metadata-only

Application of anti-CD44v6 immunoconjugate Bivatuzumab Mertansine during fractionated irradiation improves local tumor control in human FaDu-epitheliomas

Creators

  • 1. Klinik und Poliklinik fuer Strahlentherapie und Radioonkologie, Medizinische Fakultaet, Technische Univ. Dresden (Germany)
  • 2. Boehringer Ingelheim Austria GmbH, Wien (Austria)
  • 3. Experimentelles Zentrum, Medizinische Fakultaet, Technische Univ. Dresden (Germany)

Description

no abstract available

Part of:
Experimental radiotherapy and clinical radiobiology. Vol. 15

Additional details

Additional titles

Original title (German)
Applikation des anti-CD44v6 Immunkonjugates Bivatuzumab Mertansine waehrend fraktionierter Bestrahlung verbessert die lokale Tumorkontrolle in humanen FaDu-Plattenepithelkarzinomen

Publishing Information

Imprint Title
Experimental radiotherapy and clinical radiobiology. Vol. 15
Imprint Pagination
172 p.
Journal Page Range
p. 125-128
ISSN
1432-864X

Conference

Title
15. Symposium on experimental radiotherapy and clinical radiobiology
Original Conference Title
15. Symposium Experimentelle Strahlentherapie und Klinische Strahlenbiologie
Dates
2-4 Mar 2006
Place
Dresden (Germany)

INIS

Country of Publication
Germany
Country of Input or Organization
Germany
INIS RN
37055580
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference, No Abstract, Non-conventional Literature
Descriptors DEI
ANTIBIOTICS; ANTIBODIES; COMBINED THERAPY; EFFICIENCY; EPITHELIOMAS; FRACTIONATED IRRADIATION; GRAFTS; GROWTH; IMMUNOTHERAPY; MICE
Descriptors DEC
ANIMALS; ANTI-INFECTIVE AGENTS; CARCINOMAS; DISEASES; DRUGS; IRRADIATION; MAMMALS; MEDICINE; NEOPLASMS; ORGANIC COMPOUNDS; RODENTS; THERAPY; TRANSPLANTS; VERTEBRATES

Optional Information

Notes
Imprint:Experimentelle Strahlentherapie und Klinische Strahlenbiologie. Bd. 15. Proceedings